Oil-price volatility from the Iran war is upending stock, bond and gold correlations, boosting hybrid options.
Blue Owl's portfolio is heavily exposed to software, a sector facing loan defaults and market skepticism. Find out why I ...
Long-term results from the OLYMPIA open-label extension study show that nemolizumab (Nemluvio) provides durable efficacy and good tolerability for up to 3 years in patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results